Since the MIpact study is multinational I thought it might be interesting to see what other contributing centers might have in their registries. I posed this question. I have pages of data as a result and since some are experiencing data fatigue I will only post the question to Claude.
The recent Kuykendall poster at ASCO showed an unexpected prolongation of OS in MF patients. Can you compare this data to other data sets in non US registries? Especially since 2019 What is an accepted R/R to JAKi os for MF
Widening the net
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Re: Widening the net
We’ll have the real deal data soon, but not soon enough…